This is because the histologic grading criteria alone are unable to stratify prognosis in meningioma, and TERTp mutation and CDKN2A/B homozygous deletion are independent prognostic markers in grade 1 and grade 2 meningiomas [3–5]. The gene discussed is CDKN2A; the disease is meningioma.